Respirapath™

Respirapath™

Patients often have fever, cough, nasal congestion, body pain, or fatigue. When left untreated or improperly diagnosed, this could lead to hospitalization or, too often, death. Immunocompromised adults are highly susceptible and suffer from additional pathogens such as Mycobacterium avium, M. kansasii and M. tuberculosis. Children often display symptoms including whooping cough (Bordetella pertussis) and diphtheria (Corynebacterium diphtheriae).

Several notorious viruses cause respiratory illness, such as Influenza (A, H1, H3 & B), Respiratory Syncytial Virus (A & B), Parainfluneza (1-4), Coronavirus (229E, OC43, NL63 & HKU), Adenovirus, Bocavirus, Enterovirus Human Metapneumovirus and Rhinovirus. Several bacterial species also typically cause respiratory symptoms and diseases including Chlamydia pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Streptococcus pneumoniae, S. pyogenes and Staphylococcus aureus.

Immunocompromised adults are highly susceptible and suffer from additional pathogens such as Mycobacterium avium, M. kansasii and M. tuberculosis. Children often display symptoms including whooping cough (Bordetella pertussis) and diphtheria (Corynebacterium diphtheriae).

NCF Diagnostics and DNA Technologies developed the RespiraPath™ test to assist in the diagnosis of these specific respiratory illnesses. Since 2017, 75,000 patients from clinics located all over the United States have been diagnosed using RespiraPath™. Targeted treatment plans could now be precisely developed for each individual patient based on their specific test results and personal pathogen profile.

The RespiraPath™ test kit can be ordered from NCF Diagnostics and DNA Technologies for swab collection and includes all of the necessary items needed for collection and overnight delivery to our laboratory via the NCF express courier system.

Download 2021 NCF_RespiraPath_Requisition Form
Download 2021 NCF_SinoPath_Requisition Form